Five Prime Therapeutics Inc Balance Sheet Statement

FPRX $21.26 -1.1 -4.7%

03/03/21

Speculative, Mid Cap, High Flyer

Market Cap £701.9m

Enterprise Value £622.1m

Revenue £12.3m

Quality

Value

Momentum

StockRank™

To unlock Five Prime Therapeutics Inc's balance sheet statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Total Receivables, Net
Prepaid Expenses
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Other Long Term Assets, Total
Total Assets

Accounts Payable
Accrued Expenses
Notes Payable/Short Term Debt
Other Current Liabilities, Total
Total Current Liabilities

Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Preferred Stock - Non Redeemable, Net
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.